HBC Hofseth BioCare ASA
Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, Turkey, rest of Europe, Japan, Asia, and the United States. The company offers ProGo, a bioactive peptide for weight management and metabolic health; OmeGo, a fish oil that provides a full spectrum of fatty acids and omegas; CalGo and NT-II, which are calcium collagen complexes that support joint and bone health; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was founded in 2000 and is headquartered in Ålesund, Norway.…
Industry Peers
Packaged FoodsKey Statistics
About Hofseth BioCare (OSL: HBC)
›
Hofseth BioCare (OSL: HBC) is listed on Oslo Børs, where its shares trade in NOK. It belongs to the Packaged Foods industry, part of the Consumer Defensive sector, and reports about 78 employees.
The shares were at 1.050 NOK on 19 November 2026, down 41.0% over 52 weeks. Its 52-week range is 1.000 NOK to 2.010 NOK: the price is 47.8% below the high and 5.0% above the low.
Its market capitalisation is 531.79M NOK.
Hofseth BioCare reports return on equity of 180.2%, an operating margin of -33.0% and revenue up 52.1% year over year.
Its debt exceeds its cash by 248.42M NOK. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.